Informed Vital Core Application (IVC App)
Mindset Medical, Inc. • Cardiovascular • 11/18/2024
Device Purpose
The Mindset Medical, Inc. IVC App is a software-based medical device designed for non-invasive, spot pulse rate measurement using common smart device cameras. It employs remote plethysmography (rPPG) by detecting subtle facial color variations and has demonstrated accuracy and comparability through extensive testing and clinical studies.
Summary
Mindset Medical, Inc. has developed the Informed Vital Core Application (IVC App), a software-based product designed for the non-invasive spot measurement of pulse rate. Following a thorough evaluation, this device has been determined to be comparable to other similar medical products already available, allowing it to be introduced for widespread use. The IVC App is intended for adult patients aged 22 years or older in settings such as homes, hospitals, clinics, and long-term care facilities. It is not designed for critical care, continuous vital signs monitoring, or to independently direct therapy. Operating as a Software as a Medical Device (SaMD), the IVC App utilizes existing optical camera technology in common smart devices like phones, tablets, and computers. It employs remote plethysmography (rPPG) to estimate pulse rate by detecting subtle color variations in the patient's face. Extensive testing, including software verification, validation, hardware compatibility, human factors, and cybersecurity assessments, confirmed its performance. Clinical studies also demonstrated the device's accuracy in pulse rate measurements.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What are the specific accuracy metrics (e.g., mean absolute error, standard deviation) demonstrated in the clinical studies for the IVC App's pulse rate measurements?; How does the IVC App's performance compare to traditional pulse oximetry or ECG-based pulse rate monitoring in diverse patient populations or skin tones?; What are the limitations or specific environmental conditions that might affect the IVC App's rPPG accuracy (e.g., lighting, patient movement, facial hair)?; Given its SaMD classification, what cybersecurity measures are in place to protect patient data and prevent unauthorized access or manipulation of the device's functionality?; What are the long-term plans for IVC App integration with electronic health records (EHRs) or telehealth platforms, and what regulatory considerations apply to such integrations?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, HBOM, OBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly